On the other hand, the reciprocal experiment in which the host cells express 4-1BB, but transferred T cells do not, also allowed anti-4-1BB to increase the effectiveness of the adoptive immunotherapy, indicating that either host cells or adoptively transferred T cells were necessary and sufficient for the effect of agonist anti-4-1BB on tumor growth. This evidence concerns the gene TNFRSF9 and neoplasm.